Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. - Concepedia

Concepedia

Publication | Closed Access

Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.

182

Citations

21

References

1991

Year

Timo Strandberg, Veikko Salomaa, V Naukkarinen, Hannu Vanhanen, Seppo Sarna, T.A. Miettinen

Abstract

These unexpected results may not question multifactorial prevention as such but do support the need for research on the selection and interaction(s) of methods used in the primary prevention of cardiovascular diseases.

References

	Year	Citations
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Stephen MacMahon The Lancet HypertensionBlood PressureCardiovascular DiseaseHealth PolicyRegression Dilution Bias	1990	4.3K
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia M. H. Frick, Olli Elo, Kauko Haapa, New England Journal of Medicine	1987	3.9K
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. David J. Gordon, Jeffrey L. Probstfield, Robert J. Garrison, Circulation Metabolic SyndromeEpidemiologyHigh-density Lipoprotein CholesterolCardiovascular EpidemiologyHealth Policy	1989	3.2K
Can lifestyle changes reverse coronary heart disease? Dean Ornish, Shirley Brown, J. H. Billings, The Lancet Lifestyle ModificationCardiovascular DiseaseHealth PolicyCardiologyCardiovascular Risk Factors	1990	2.1K
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin Paul L. Canner, Kenneth G. Berge, Nanette K. Wenger, Journal of the American College of Cardiology Cardiovascular DiseaseHealth PolicyLong-term BenefitCardiovascular PharmacologyFifteen Year Mortality	1986	1.8K
Clofibrate and Niacin in Coronary Heart Disease JAMA	1975	1.7K
EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Ingvar Hjermann, Ingar Holme, K.Velve Byre, The Lancet Tobacco ControlNutritionLifestyle ModificationCardiovascular EpidemiologyHealth Policy	1981	1K
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia Hēnry Buchwald, Richard L. Varco, John P. Matts, New England Journal of Medicine	1990	1K
BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE JohnM. Cruickshank, J.M. Thorp, F. J. Zacharias The Lancet Antihypertensive TherapyHypertensionBlood PressureCardiovascular Disease	1987	663
Treatment of mild hypertension: A five year controlled drug trial Anders Helgeland The American Journal of Medicine Non-pharmacological InterventionHypertensionCardiovascular DiseaseAntihypertensive AgentsMild Hypertension	1980	654

Page 1